Pages that link to "Glossary:TAG-00051-Eth-ngs"

The following pages link to Glossary:TAG-00051-Eth-ngs:

Displaying 32 items.

• Glossary (← links)
• Reference:INT Nuremberg Code 1947 Code (← links)
• Reference:WMA Declaration of Helsinki 2024 - (← links)
• Reference:WHO WHO - HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP) 2005 WHO Principles of GCP (← links)
• Reference:EUR European Bioethics Convention 1997 - (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) I (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) II (← links)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 62 Paragraph 3 (← links)
• Reference:DEU MBO - Berufsordnung der Ärzt:innen 11-Jun-2021 § 15 (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 3.2 - Introduction (← links)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 3.26 (← links)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 23 (← links)
• Reference:CIOMS CIOMS - International Ethical Guidelines for Biomedical Research Involving Human Subjects 2016 Page 20 (← links)
• Reference:DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 1 1.1 ; 1.3 (← links)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 4 (← links)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 62 Paragraph 3 & 4 (← links)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 50 (← links)
• Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 2.7.5 (← links)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 22 (← links)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 9 (← links)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 25 – 28 (← links)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 31 – 32 (← links)
• Reference:DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 1 1.2 (← links)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 17 (← links)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 23 - Amendment approval (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 3.2 - Responsibility (← links)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 23 - Oversight (← links)
• Reference:WMA Declaration of Helsinki 2024 34 (← links)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 23 - Final report (← links)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 36 (← links)
• Reference:GBR Directive 93/42/EEC 11-Oct-2007 Annex X 2.2 (← links)
• Reference:WHO WHO Good Practices for Clinical Trial Design and Implementation 04-May-2026 - (← links)